Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Thymoma 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Radiation Pneumonitis 1Pneumonia 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Myasthenia Gravis 1Melanoma 1Lung Diseases, Interstitial 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colitis 1Carcinoma, Renal Cell 1Advanced Squamous Non Small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

nintedanib 2durvalumab 2Radiotherapy 2tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1camrelizumab 1aumolertinib 1atezolizumab 1Tomography, Emission-Computed, Single-Photon 1Surveys and Questionnaires 1Respiratory Function Tests 1Prednisone 1Nivolumab 1Immunotherapy 1Immunoglobulin G 1Enalapril 1Disulfides 1Dexamethasone 1Cisplatin 1Breath Holding 1Adrenal Cortex Hormones 1Adjuvants, Immunologic 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Pneumonitis × Prednisone × Thoracic × Clear all
NCT02496585 2025-04-16

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
34 enrolled 10 charts
Thoracic

Lung Neoplasms, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡